Skip to main content

Advertisement

SpringerLink
Log in

Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background

Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB.

Materials and methods

Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection.

Results

CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay.

Conclusion

Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Koulenti D, Rello J. Gram-negative bacterial pneumonia: aetiology and management. Curr Opin Pulm Med. 2006;12:198–204.

    CAS  PubMed  Google Scholar 

  2. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivete SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–9.

    PubMed  Google Scholar 

  3. Falguera M, Carratala J, Ruiz-Gonzalez A, García-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM. Risk factors and outcome of community acquired pneumonia due to Gram-negative bacilli. Respirology. 2009;14:105–11.

    Article  PubMed  Google Scholar 

  4. Arancibia F, Bauer T, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A. Community acquired pneumonia due to gram negative bacteria and Pseudomonas aeruginosa. Arch Intern Med. 2002;162:1849–58.

    Article  PubMed  Google Scholar 

  5. Kang CI, Song JH, Oh WS, Ko KS, Chung DR, Peck KR. Clinical outcomes and risk factors of community acquired pneumonia caused by gram negative bacilli. Eur J Clin Microbiol Infect Dis. 2008;27:657–61.

    Article  PubMed  Google Scholar 

  6. Bartlett JG, Breiman RF, Mandell LA, File TM, The Infectious Disease Society of America. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 1998;26:811–38.

    Article  CAS  PubMed  Google Scholar 

  7. American Thoracic Society. Guidelines for the management of adults with community acquired pneumonia. Am J Respir Crit Care Med. 2001;163:1730–54.

    Google Scholar 

  8. Metersky ML, Ma A, Bratzier DW, Houck PM. Predicting bacteraemia in patients with community acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342–7.

    Article  PubMed  Google Scholar 

  9. Falguera M, Trujillano J, Caro S, Menéndez R, Carratalá J, Ruiz-González A, Vilà M, García M, Porcel JM, Torres A, NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecciones Respiratorias de Vías Bajas) Study Group. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009; 49:409–16.

    Google Scholar 

  10. Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalization: 5 year prospective study. Rev Infect Dis. 1989;2:586–99.

    Google Scholar 

  11. Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacain R, Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR: Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad (Sociedad Española de Neumología y Cirugía Torácica). Arch Bronconeumol 2005; 41:272–89.

    Google Scholar 

  12. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoon WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.

    Article  CAS  PubMed  Google Scholar 

  13. Dorca J, Bello S, Blanquer J, de Celis R, Molinos L, Torres A, Verano A, Zalacain R. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol. 1997;33:240–6.

    CAS  PubMed  Google Scholar 

  14. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community acquired pneumonia. Am J Respir Crit Care Med. 2006;174:1249–56.

    Article  PubMed  Google Scholar 

  15. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250–6.

  16. Ko WC, Paterson D, Sagnimeni A, Hansen D, Von Gotteborg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. Community acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8:160–6.

    Article  PubMed  Google Scholar 

  17. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006;129:102–9.

    Article  PubMed  Google Scholar 

  18. García Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008;27:901–6.

    Article  Google Scholar 

  19. Allen MB, Prowse K. Bacteraemic Haemophilus influenzae pneumonia. Eur Respir J. 1988;1:929–31.

    CAS  PubMed  Google Scholar 

  20. Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006;6:419–24.

    Article  Google Scholar 

  21. Menéndez R, Torres A, Zalacain R, Aspa J, Martín-Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez CJ, Molinos L, Neumofail Group. Risk factors to treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960–5.

    Article  PubMed  Google Scholar 

  22. Charles P, Wolf R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375–84.

    Google Scholar 

  23. Kang CL, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–6.

    Article  CAS  PubMed  Google Scholar 

  24. Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis. 1998;2:211–5.

    Article  CAS  PubMed  Google Scholar 

  25. Osih RB, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of empirical antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2007;51:839–44.

    Article  CAS  PubMed  Google Scholar 

  26. Menéndez R, Torres A, Zalacain R, Aspa J, Martín J, Borderías L, Benítez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez C, Molinos L, NEUMOFAIL Group. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med. 2005;172:757–62.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

No financial support was received for this study.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Pneumology Service, Hospital de Cruces, 48903, Cruces-Barakaldo, Bizkaia, Spain

    L. A. Ruiz, A. Gómez, C. Jaca, B. Gómez & R. Zalacain

  2. Epidemiology Unit, Hospital de Cruces, 48903, Cruces-Barakaldo, Bizkaia, Spain

    L. Martínez

Authors
  1. L. A. Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Jaca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Zalacain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. A. Ruiz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruiz, L.A., Gómez, A., Jaca, C. et al. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection 38, 453–458 (2010). https://doi.org/10.1007/s15010-010-0058-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-010-0058-4

Keywords

Search

Navigation